DVx Inc.
DVx Inc. (3079.T) Stock Competitors & Peer Comparison
See (3079.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3079.T | ¥1,054.00 | -0.19% | 11B | 26.90 | ¥39.18 | +4.73% |
| 6849.T | ¥1,659.50 | +0.27% | 270.6B | 19.55 | ¥84.90 | +1.87% |
| 6960.T | ¥6,950.00 | +2.51% | 189.5B | 10.77 | ¥645.46 | +2.88% |
| 6523.T | ¥1,025.00 | -1.73% | 129.7B | 12.41 | ¥82.61 | +4.03% |
| 7575.T | ¥1,457.00 | -1.15% | 102.2B | 11.08 | ¥131.48 | +3.60% |
| 4549.T | ¥2,419.00 | +1.26% | 79.1B | 37.64 | ¥64.26 | +2.22% |
| 4548.T | ¥661.00 | -1.05% | 36.1B | 29.72 | ¥22.24 | +4.49% |
| 6823.T | ¥2,656.00 | -1.59% | 32.7B | 11.44 | ¥232.11 | +2.41% |
| 7779.T | ¥212.00 | -3.64% | 28.3B | -77.66 | -¥2.73 | N/A |
| 7777.T | ¥221.00 | +1.38% | 24.8B | -8.77 | -¥25.20 | N/A |
Stock Comparison
3079.T vs 6849.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 6849.T has a market cap of 270.6B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 6849.T trades at ¥1,659.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 6849.T's P/E ratio is 19.55. In terms of profitability, 3079.T's ROE is +0.05%, compared to 6849.T's ROE of +0.08%. Regarding short-term risk, 3079.T is less volatile compared to 6849.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 6849.T's competition here
3079.T vs 6960.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 6960.T has a market cap of 189.5B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 6960.T trades at ¥6,950.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 6960.T's P/E ratio is 10.77. In terms of profitability, 3079.T's ROE is +0.05%, compared to 6960.T's ROE of +0.11%. Regarding short-term risk, 3079.T is less volatile compared to 6960.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 6960.T's competition here
3079.T vs 6523.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 6523.T has a market cap of 129.7B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 6523.T trades at ¥1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 6523.T's P/E ratio is 12.41. In terms of profitability, 3079.T's ROE is +0.05%, compared to 6523.T's ROE of +0.07%. Regarding short-term risk, 3079.T is less volatile compared to 6523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 6523.T's competition here
3079.T vs 7575.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7575.T has a market cap of 102.2B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7575.T trades at ¥1,457.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7575.T's P/E ratio is 11.08. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7575.T's ROE of +0.17%. Regarding short-term risk, 3079.T is less volatile compared to 7575.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 7575.T's competition here
3079.T vs 4549.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 4549.T has a market cap of 79.1B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 4549.T trades at ¥2,419.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 4549.T's P/E ratio is 37.64. In terms of profitability, 3079.T's ROE is +0.05%, compared to 4549.T's ROE of +0.05%. Regarding short-term risk, 3079.T is less volatile compared to 4549.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 4549.T's competition here
3079.T vs 4548.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 4548.T has a market cap of 36.1B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 4548.T trades at ¥661.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 4548.T's P/E ratio is 29.72. In terms of profitability, 3079.T's ROE is +0.05%, compared to 4548.T's ROE of +0.02%. Regarding short-term risk, 3079.T is less volatile compared to 4548.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 4548.T's competition here
3079.T vs 6823.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 6823.T has a market cap of 32.7B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 6823.T trades at ¥2,656.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 6823.T's P/E ratio is 11.44. In terms of profitability, 3079.T's ROE is +0.05%, compared to 6823.T's ROE of +0.09%. Regarding short-term risk, 3079.T is less volatile compared to 6823.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 6823.T's competition here
3079.T vs 7779.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7779.T has a market cap of 28.3B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7779.T trades at ¥212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7779.T's P/E ratio is -77.66. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7779.T's ROE of -0.01%. Regarding short-term risk, 3079.T is less volatile compared to 7779.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 7779.T's competition here
3079.T vs 7777.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7777.T has a market cap of 24.8B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7777.T trades at ¥221.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7777.T's P/E ratio is -8.77. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7777.T's ROE of -1.30%. Regarding short-term risk, 3079.T is less volatile compared to 7777.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 7777.T's competition here
3079.T vs 7600.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7600.T has a market cap of 14B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7600.T trades at ¥530.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7600.T's P/E ratio is -30.22. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7600.T's ROE of -0.02%. Regarding short-term risk, 3079.T is more volatile compared to 7600.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3079.T.Check 7600.T's competition here
3079.T vs 6678.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 6678.T has a market cap of 13.7B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 6678.T trades at ¥1,979.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 6678.T's P/E ratio is 13.65. In terms of profitability, 3079.T's ROE is +0.05%, compared to 6678.T's ROE of +0.07%. Regarding short-term risk, 3079.T is less volatile compared to 6678.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 6678.T's competition here
3079.T vs 7792.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7792.T has a market cap of 13.1B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7792.T trades at ¥1,440.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7792.T's P/E ratio is 10.40. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7792.T's ROE of +0.30%. Regarding short-term risk, 3079.T is less volatile compared to 7792.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3079.T.Check 7792.T's competition here
3079.T vs 7963.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 7963.T has a market cap of 8.7B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 7963.T trades at ¥1,777.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 7963.T's P/E ratio is 11.29. In terms of profitability, 3079.T's ROE is +0.05%, compared to 7963.T's ROE of +0.06%. Regarding short-term risk, 3079.T is more volatile compared to 7963.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3079.T.Check 7963.T's competition here
3079.T vs 5187.T Comparison August 2025
3079.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3079.T stands at 11B. In comparison, 5187.T has a market cap of 8.3B. Regarding current trading prices, 3079.T is priced at ¥1,054.00, while 5187.T trades at ¥985.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3079.T currently has a P/E ratio of 26.90, whereas 5187.T's P/E ratio is 11.95. In terms of profitability, 3079.T's ROE is +0.05%, compared to 5187.T's ROE of +0.06%. Regarding short-term risk, 3079.T is more volatile compared to 5187.T. This indicates potentially higher risk in terms of short-term price fluctuations for 3079.T.Check 5187.T's competition here